| |
Tuesday, April 4, 2023 | 10am ET / 7am PT Life sciences leaders are reporting that investments in cloud technology are opening new doors for enhanced productivity, improved time-to-insights, and more. Join this one-hour deep dive into the latest solutions and strategies for successfully accelerating innovation while optimizing costs. Register now.
|
|
Today's Big NewsApr 20, 2023 |
|
May 1 - 3, 2023 | Jersey City, NJ Examine how the current changes to field medical will affect the role moving forward. Only a few weeks left, Register Today!
|
|
| By Nick Paul Taylor The nine-year wait for new clinical data on Promore Pharma’s ensereptide has ended in disaster, with the failure of the polypeptide to reduce scarring in a midphase trial wounding the biotech’s share price. |
|
|
|
By Max Bayer Abdera is unveiling with $142 million in combined series A and B cash to build out a new wave of radiopharmaceuticals. The biotech is planning to ask the FDA to enter clinical trials with a lead asset in 2024. |
By Nick Paul Taylor Bristol Myers Squibb is getting deeper into antibody-drug conjugates, paying Tubulis $22.8 million upfront to access technology designed to create more stable drugs with improved risk-benefit profiles. |
Sponsored by YPrime Michael Hughes, Chief Product Officer at YPrime discusses the benefits and challenges of eConsent implementation and how to circumvent the biggest barriers to adoption. |
By Gabrielle Masson,Max Bayer,Annalee Armstrong Alongside the new year, we've launched a new Fierce Biotech Fundraising Tracker to keep the pulse on the industry's financing. |
By Fraiser Kansteiner Not one, not two, but three of the industry's top diabetes players last month slashed prices on their competing insulins. After Eli Lilly's move, the strategy was quickly picked up by Novo Nordisk and Sanofi, drawing praise from lawmakers and advocacy groups alike. So, what was behind the sudden change? |
By Andrea Park Less than a year after putting down $240 million to acquire Ivenix and its sensor- and software-backed infusion pump, Fresenius Kabi is recalling more than 1,500 of the systems. |
By Joseph Keenan A recent study conducted by cloud healthcare software provider Veeva says on-time data entry and data quality are the top challenges for medtech companies working with clinical research sites. |
By Andrea Park True to its namesake, Intuitive Surgical’s da Vinci robotic surgery system has become increasingly prolific amid the current renaissance period—as in, the resurgence of regular healthcare procedures as the COVID-19 pandemic transitions into an endemic. |
By Heather Landi CHICAGO—Epic’s Phil Lindemann chatted on the show floor at the HIMSS 2023 conference about the EHR giant's work to integrate GPT-4 into its EHR and is expanding work in genomics and life sciences. |
Fierce podcastsDon't miss an episode |
| | This week on "The Top Line," we talk about biotech’s top money raisers in 2022. We also cover J&J's talc litigation, prison plans for Elizabeth Holmes and more of this week's top headlines. |
|
|---|
|
|
| ResearchStrategies for Optimal Site Selection and Feasibility Research in Novel Therapies and Geographies Sponsored by: H1 |
| Whitepaper How can eConsent provide a more flexible approach to informed consent? Sponsored by: YPrime |
| Whitepaper The preclinical hematotoxicity screening method that helps clients eliminate bad players earlier in the drug development process Sponsored by: ReachBio | The Cell Biology Experts™ |
| Whitepaper We’ve identified four must-have tools to manage today’s scientific information chaos. How many are you utilizing? Sponsored By: CCC |
| Whitepaper How advanced medicines commercial readiness differs and the resources needed to maximize potential. Sponsored by: Herspiegel Consulting |
| WhitepaperThis paper outlines an approach that digital health / therapeutics companies can use when developing a go-to-market strategy for the complex US market. Presented by Blue Matter, strategic consultants in the life sciences |
| Whitepaper Preparation of critical process liquids and buffer components shifts resources away from core activities and can be filled with inefficiencies and risks that can increase time and costs across your workflow. Learn about the framework to help reduce your total costs beyond capital and operational expenditures and set a solid foundation for successful scale-up of buffer preparation. Sponsored by: Thermo Scientific Production Chemicals and Services |
| WhitepaperExplore how clinical supply can be scaled up as decentralized programs progress, and how technological solutions can accelerate trial deployment. Sponsored by: Catalent Clinical Supply |
| Whitepaper As sponsors increasingly look to CROs to support their clinical studies, making and addressing certain clinical supply considerations at the outset of the relationship can reduce the risk of potentially unforeseen impact to budget and time later. Discover key issues sponsors should consider to help their CRO or partner of choice better understand their clinical supply needs. Sponsored by: Catalent |
| WhitepaperFor sponsors, cost is a key concern when it comes to managing the supply of their clinical trials. A financial project analyst (FPA) is a specialized expert who can help control clinical supply costs and keep the project within budget. Explore the critical role that a Financial Project Analyst plays in clinical trial supply and budget management. Sponsored by: Catalent |
| WhitepaperLearn how Catalent’s extensive network across APAC can meet a wide range of clinical supply needs for sponsors conducting trials within the region. Sponsored by: Catalent |
| WhitepaperDiscover key considerations that every trial sponsor should know when navigating the complex clinical supply distribution landscape across Asia-Pacific. Sponsored by: Catalent |
| WhitepaperHow can specialized expertise help you optimize your clinical supply chain? Learn about the roles and responsibilities of unique experts such as clinical supply management, project management, and financial project analysis. Sponsored by: Catalent Clinical Supply |
| WhitepaperExplore Catalent’s newest clinical supply facility in Japan, including the comprehensive services & solutions it offers to help support trials both in-country & around the world. Sponsored by: Catalent |
| WhitepaperPlanning on using a CRO to support your next clinical study? This infographic outlines critical areas to address at the start of the relationship in order to ensure that budget and timelines keep on track for the duration of the trial. Sponsored by: Catalent |
| |
|
